Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents
Arteriosclerosis, Thrombosis, and Vascular Biology. 1989;9:684-689

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNicol, A.
Right arrow Articles by Gerrard, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNicol, A.
Right arrow Articles by Gerrard, J. M.

Arteriosclerosis, Vol 9, 684-689, Copyright © 1989 by American Heart Association

ARTICLES

A role for intracellular histamine in ultrastructural changes induced in platelets by phorbol esters

A McNicol, SP Saxena, LJ Brandes and JM Gerrard
Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada.

In human platelets, phorbol esters, such as phorbol-12-myristate-13- acetate (PMA), induce morphological changes, including pseudopod formation and the swelling and fusion of intracellular granule membranes with those of the surface-connected canalicular system, effects which have been attributed to activation of protein kinase C. However, a novel intracellular histamine antagonist, N,N-diethyl-2-[4- (phenylmethyl)phenoxy]-ethanamine. HCl (DPPE), previously has been shown to block PMA-induced aggregation independently of protein kinase C interaction, an effect reversible in permeabilized platelets by the addition of histamine. We now demonstrate that DPPE inhibits, in a concentration-dependent manner, the effects of PMA on human platelet ultrastructure. In permeabilized platelets, histamine reverses this inhibition, although it alone induces minimal effects on morphology. The results support a role for this amine to promote the labilization of platelet granules and pseudopod formation induced by PMA, presumably by acting in concert with additional PMA-activated pathways.


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
M. Bertagnolli, S. Locke, M. Hensler, P. Bray, and M. Beckerle
Talin distribution and phosphorylation in thrombin-activated platelets
J. Cell Sci., January 12, 1993; 106(4): 1189 - 1199.
[Abstract] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.